CV · CapsoVision, Inc
$6.37
+0.01 (+0.16%)
At close · Sep 9
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company, having evaluated the extant facts and circumstances, concluded that the facts and circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of issuance of these financial statements. While the Company raised approximately $14 million in gross proceeds resulting from the Private Placement described in Note 1. DESCRIPTION OF BUSINESS AND ORGANIZATIONAL STRUCTURE and further discussed in Note 9. COMMON STOCK, it is not probable that these funds are sufficient to fund expenditures necessary to achieve sales growth and innovation objectives. The Company intends to consummate additional capital raising activities, but there is no certainty as to such capital raising activities occurring at all, or occurring with sufficient timing or magnitude, sufficient to alleviate such substantial doubt.”View the 10-Q filed Aug 13, 2026
Market Cap
$318.30M
Shares
50.05M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.37
Open$6.30
Day$6.24–6.68
52W close$3.56–14.42
Avg vol 30d100K
Short int1.8M · 3.6% float · 17.1d
Short vol80%
Last earningsAug 13, 2026
DataJul 2025–Sep 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 12, 2026
Est · unconfirmed
· in 9 wks
filed Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$13.89M
Trailing 12 months
Net income (TTM)
−$29.83M
Trailing 12 months
Revenue growth YoY
+9.9%
Year over year
Operating margin
-217.1%
Trailing 12 months
P / E (TTM)
2.0
Trailing earnings · reciprocal yield 50.0%
FCF yield
-8.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2,078.6%
Year over year · more shares
Price change (1Y)
+74.7%
Trailing year
Short interest
3.6%
Latest settlement · 17.1 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.7 · calm
Equity put/call 0.48
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−6%
below
Price vs 50-day avg
−1%
below
RSI (14)
54
neutral
MACD trend
Positive
52-week position
26%
mid-range
Momentum
relative strength
1-month return
−3%
trailing
6-month return
+17%
trailing
YTD return
−40%
this year
Relative strength
+2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +6 funds added
Insider flow
Accumulating
Net +$1.0M over 90 days · 0% sells
Short interest
Falling
3.57% of float · ▼ -6.7% MoM · 17.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
50 holders — near 1-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+15%
Y/Y
Gross margin
53%
contracting
EPS growth
+90%
Y/Y
Free cash flow
$-23.0M
Quant / Vol
risk profile
Volatility
98%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
5.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−6%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
26%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +6 funds added
Insider flow
Accumulating
Net +$1.0M over 90 days · 0% sells
Short interest
Falling
3.57% of float · ▼ -6.7% MoM · 17.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
50 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $4
Now $6 · 26%
Range high $14
vs 200-day avg -6%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CV
this stock
CapsoVision, Inc
|
$318.30M | -40.4% | +15.3% | — | 3.6% |
|
ABT
Abbott Laboratories
|
$188.69B | -15.8% | +5.7% | 30.3 | 1.2% |
|
MDT
Medtronic plc
|
$118.41B | -3.8% | +8.4% | 22.8 | 1.1% |
|
SYK
Stryker Corp
|
$116.27B | -21.4% | +11.2% | 31.4 | 1.8% |
|
BSX
Boston Scientific Corp
|
$66.11B | -52.8% | +12.5% | 18.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CV | +8.5% | -3.5% | +16.7% | +9.1% | -40.4% |
| SPY | -0.1% | -0.9% | +14.2% | -0.1% | +12.3% |
| vs SPY | +8.7% | -2.6% | +2.5% | +9.2% | -52.7% |
Key facts
CIK
1378325
CUSIP
140935107
13F (30d)
33 filings
33 filers
Visit website
Investor relations